Page URL: https://www.bionews.org.uk/page_92325

Heart bypass 'leftovers' yield stem cells

4 May 2010
Appeared in BioNews 556

Stem cells have been successfully extracted from veins left over from heart bypass surgery. Scientists hope that such cells could be used in the treatment of future heart conditions by stimulating the growth of new arteries.

The scientific breakthrough was published in a recent edition of the peer-reviewed journal Circulation. The study was a collaborative effort between researchers at the University of Bristol, UK, and the University of Udine, Italy, funded by the British Heart Foundation and the UK's National Institute for Health Research. Professor Peter Weissberg, medical director of the British Heart Foundation, described the results as very encouraging, bringing the possibility of 'cell therapy' for damaged hearts one step closer.

The researchers investigated whether stem cells could be extracted from leg veins used in coronary artery bypass surgery. Stem cells are undifferentiated (immature) cells with the ability to become any specific type of cell. Using just four to five centimetre portions of leg vein the scientists were successfully able to isolate stem cells. The research team then used these cells to generate a large number of stem cells in culture. The newly generated cells were injected into mice with a restricted blood supply. The injection stimulated new blood vessel growth and improved blood flow compared with placebo injections.

Lead researcher on the study, Professor Paolo Madeddu from the University of Bristol, told BBC News Online that this is the first time that scientists have been able to extract stem cells from portions of vein left over from heart operations. He suggested that this advance might make it possible for a patient having heart bypass surgery to also receive heart treatment using their own body's stem cells. The researchers were quick to emphasise that much more work will be necessary before the cells can be used in humans.

Surgeons performing bypass surgery routinely take slightly more vein than is required, so these leftover portions of leg vein would be a convenient source of stem cells. The use of leg veins would also allow researchers to side-step some of the ethical dilemmas associated with stem cell research, such as the use of embryos in the laboratory to obtain embryonic stem cells.

SOURCES & REFERENCES
'Leftover' stem cells may aid recovery
NHS Choices |  26 April 2010
'Leftover' veins from heart surgery yield stem cells
BBC News |  24 April 2010
Stem cell breakthrough gives heart patients hope
The Guardian |  25 April 2010
Stem cell discovery to mend heart damage
The Medguru |  26 April 2010
RELATED ARTICLES FROM THE BIONEWS ARCHIVE
28 November 2011 - by Dr Sophie Pryor 
Mouse fetal stem cells can travel from the placenta to heal their mother's damaged heart, US scientists have found. The discovery may explain why some women who suffer heart failure during or shortly after pregnancy recover faster, and offers hope for new treatment methods using human fetal stem cells...
21 November 2011 - by Victoria Kay 
The world's first clinical trial using patients' own cardiac stem cells to repair heart damage has produced surprising results. The preliminary trial was designed simply to test the safety of the procedure, but doctors observed an unexpected improvement in heart function in patients receiving the treatment...
12 September 2011 - by Rosie Beauchamp 
An Australian company has announced it has received regulatory approval from the European Medicines Agency (EMA) to begin phase II trials for its cardiovascular stem cell treatment, Revascor....
16 August 2010 - by Dr Marianne Kennedy 
An 11-year-old boy has returned home after becoming the first child to undergo a pioneering surgery which used his own stem cells to rebuild his windpipe. The operation, which took place in March this year at Great Ormond Street Hospital in London, has been hailed as 'a success'...
18 June 2010 - by Rosemary Paxman 
Functional lab-grown livers could become a reality within 5-10 years, suggests a new study published by Nature Medicine, offering hope to liver transplant patients....
HAVE YOUR SAY
Log in to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.